New cell therapy aims to stop transplant complications in blood cancer patients
Disease control
Terminated
This early-phase study tested whether a special type of cell (interferon gamma-primed mesenchymal stromal cells) could be safely given to prevent graft-versus-host disease, a common and serious complication after bone marrow transplant. Only 4 patients with acute leukemia or myel…
Phase: PHASE1 • Sponsor: Edwin Horwitz • Aim: Disease control
Last updated Jun 03, 2026 12:02 UTC